GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SeouLinBioscience Co Ltd (XKRX:038070) » Definitions » EV-to-FCF

SeouLinBioscience Co (XKRX:038070) EV-to-FCF : -41.15 (As of May. 28, 2024)


View and export this data going back to 2005. Start your Free Trial

What is SeouLinBioscience Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SeouLinBioscience Co's Enterprise Value is ₩44,127 Mil. SeouLinBioscience Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,072 Mil. Therefore, SeouLinBioscience Co's EV-to-FCF for today is -41.15.

The historical rank and industry rank for SeouLinBioscience Co's EV-to-FCF or its related term are showing as below:

XKRX:038070' s EV-to-FCF Range Over the Past 10 Years
Min: -1296.39   Med: 16.13   Max: 707.88
Current: -41.93

During the past 13 years, the highest EV-to-FCF of SeouLinBioscience Co was 707.88. The lowest was -1296.39. And the median was 16.13.

XKRX:038070's EV-to-FCF is ranked worse than
100% of 369 companies
in the Biotechnology industry
Industry Median: 8.9 vs XKRX:038070: -41.93

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-28), SeouLinBioscience Co's stock price is ₩8550.00. SeouLinBioscience Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-158.955. Therefore, SeouLinBioscience Co's PE Ratio for today is At Loss.


SeouLinBioscience Co EV-to-FCF Historical Data

The historical data trend for SeouLinBioscience Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeouLinBioscience Co EV-to-FCF Chart

SeouLinBioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.57 31.30 15.53 -12.27 -1,154.80

SeouLinBioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.92 -8.64 -6.14 -1,154.80 -52.61

Competitive Comparison of SeouLinBioscience Co's EV-to-FCF

For the Biotechnology subindustry, SeouLinBioscience Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SeouLinBioscience Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SeouLinBioscience Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where SeouLinBioscience Co's EV-to-FCF falls into.



SeouLinBioscience Co EV-to-FCF Calculation

SeouLinBioscience Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=44126.696/-1072.293
=-41.15

SeouLinBioscience Co's current Enterprise Value is ₩44,127 Mil.
SeouLinBioscience Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,072 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SeouLinBioscience Co  (XKRX:038070) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

SeouLinBioscience Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=8550.00/-158.955
=At Loss

SeouLinBioscience Co's share price for today is ₩8550.00.
SeouLinBioscience Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-158.955.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


SeouLinBioscience Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of SeouLinBioscience Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


SeouLinBioscience Co (XKRX:038070) Business Description

Traded in Other Exchanges
N/A
Address
4F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi-do, KOR, 463-400
SeouLinBioscience Co Ltd is a South Korean company operating in biotechnology industry. The company focuses on bio research and production, manufacturing, diagnostics, and healthcare.

SeouLinBioscience Co (XKRX:038070) Headlines

No Headlines